JP2015500297A - 治療方法 - Google Patents

治療方法 Download PDF

Info

Publication number
JP2015500297A
JP2015500297A JP2014546242A JP2014546242A JP2015500297A JP 2015500297 A JP2015500297 A JP 2015500297A JP 2014546242 A JP2014546242 A JP 2014546242A JP 2014546242 A JP2014546242 A JP 2014546242A JP 2015500297 A JP2015500297 A JP 2015500297A
Authority
JP
Japan
Prior art keywords
cells
mice
stem cells
hippocampus
nrp2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014546242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500297A5 (https=
Inventor
エンジェル・ロペス
クエンテン・シュワルツ
Original Assignee
メドベッド サイエンス プロプライエタリー リミテッド
メドベッド サイエンス プロプライエタリー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011905180A external-priority patent/AU2011905180A0/en
Application filed by メドベッド サイエンス プロプライエタリー リミテッド, メドベッド サイエンス プロプライエタリー リミテッド filed Critical メドベッド サイエンス プロプライエタリー リミテッド
Publication of JP2015500297A publication Critical patent/JP2015500297A/ja
Publication of JP2015500297A5 publication Critical patent/JP2015500297A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2014546242A 2011-12-13 2012-12-13 治療方法 Pending JP2015500297A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2011905180A AU2011905180A0 (en) 2011-12-13 Method of treatment
AU2011905180 2011-12-13
PCT/AU2012/001530 WO2013086574A1 (en) 2011-12-13 2012-12-13 Method of treatment

Publications (2)

Publication Number Publication Date
JP2015500297A true JP2015500297A (ja) 2015-01-05
JP2015500297A5 JP2015500297A5 (https=) 2016-02-04

Family

ID=48611719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546242A Pending JP2015500297A (ja) 2011-12-13 2012-12-13 治療方法

Country Status (9)

Country Link
US (1) US20140348793A1 (https=)
EP (1) EP2791324B1 (https=)
JP (1) JP2015500297A (https=)
KR (1) KR20140116103A (https=)
CN (1) CN104540938A (https=)
AU (1) AU2012350357A1 (https=)
CA (1) CA2859213A1 (https=)
IN (1) IN2014DN05769A (https=)
WO (1) WO2013086574A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230218213A1 (en) * 2020-07-02 2023-07-13 The Johns Hopkins University Fmri-hippocampus acoustic battery (fhab)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003572A1 (en) * 1999-03-05 2003-01-02 David J. Anderson Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
ITNA20060017A1 (it) * 2006-02-20 2007-08-21 Aquino Riccardo D Tecnica di prelievo e selezione di un una popolazione di cellule staminali di tipo embrionale da tessuti follicolari peridentari di uomo adulto.
US8815581B2 (en) * 2010-02-03 2014-08-26 Samsung Life Public Welfare Foundation Method for proliferating stem cells by activating c-MET/HGF signaling and notch signaling
WO2013040650A1 (en) * 2011-09-22 2013-03-28 Central Adelaide Local Health Network Incorporated Screening method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CELL, vol. 71, JPN6016037471, 1992, pages 973 - 985, ISSN: 0003408518 *
DEVELOPMENT, vol. 133, JPN6016037468, 2005, pages 99 - 106, ISSN: 0003408517 *

Also Published As

Publication number Publication date
WO2013086574A1 (en) 2013-06-20
CA2859213A1 (en) 2013-06-20
AU2012350357A1 (en) 2014-07-24
IN2014DN05769A (https=) 2015-04-10
EP2791324B1 (en) 2017-05-10
US20140348793A1 (en) 2014-11-27
EP2791324A1 (en) 2014-10-22
EP2791324A4 (en) 2015-04-29
KR20140116103A (ko) 2014-10-01
CN104540938A (zh) 2015-04-22

Similar Documents

Publication Publication Date Title
Shen et al. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1
Goodliffe et al. Absence of prenatal forebrain defects in the Dp (16) 1Yey/+ mouse model of Down syndrome
Whitaker-Azmitia Serotonin and brain development: role in human developmental diseases
Fedoroff Prenatal ontogenesis of astrocytes
Li et al. Neural stem cells rescue nervous Purkinje neurons by restoring molecular homeostasis of tissue plasminogen activator and downstream targets
Oaks et al. Cc2d1a loss of function disrupts functional and morphological development in forebrain neurons leading to cognitive and social deficits
Yamasaki et al. Stress-activated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex
Tóth et al. The NKCC1 ion transporter modulates microglial phenotype and inflammatory response to brain injury in a cell-autonomous manner
Noguchi et al. DNA methyltransferase 1 is indispensable for development of the hippocampal dentate gyrus
Scheinert et al. Therapeutic effects of stress-programmed lymphocytes transferred to chronically stressed mice
Pahle et al. Selective inactivation of reelin in inhibitory interneurons leads to subtle changes in the dentate gyrus but leaves cortical layering and behavior unaffected
Kojima et al. Genetic disruption of the alternative splicing of drebrin gene impairs context-dependent fear learning in adulthood
Saraceno et al. Consequences of excessive plasticity in the hippocampus induced by perinatal asphyxia
EP2791324B1 (en) Cell population for use in treating neuropsychiatric disorders
JP2004520051A6 (ja) 腸管神経系に由来する幹細胞および前駆細胞ならびにそれらの使用
JP2004520051A (ja) 腸管神経系に由来する幹細胞および前駆細胞ならびにそれらの使用
Depret Role of the planar polarity pathway in cognitive functions in the context of postnatal development and aging
Lampada et al. Stress and elevation of serotonin from the raphe nuclei induce Septal neuron production in adult mice
Sewell Determining the Role of Beta-Tubulin 4b in Cilia and Development
Daneman How is the blood-brain barrier built? The cellular and molecular interactions that regulate the formation of the blood-brain barrier
Lin Kv1. 1 regulation of adult hippocampal neurogenesis
Santhosh Brain Region Specific Neurovascular Signaling and Germinal Matrix Hemmorhage
Dorrier The Origin and Function of CNS Fibrosis
Abed The Role of Transcription Factors in Retinal Ganglion Cell Development, Maintenance, and Survival
Coelho Investigating the Pathophysiology of Maternal Inflammation-Induced Autistic-Like Phenotype: From Rodents to Primates

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151211

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151211

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20160218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161221

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170530